日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Cross-Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real-World Evidence

欧洲药品证据需求横断面调查——以真实世界证据为重点

期刊:Pharmacoepidemiology and Drug Safety
影响因子:2.4
doi:10.1002/pds.70358
Melinder, Maria; Windfuhr, Fabian; Dahlqvist, Tanja; Torre, Carla; Sepodes, Bruno; Mol, Peter G M; Almeida, Diogo; Ekheden, Isabella; Feltelius, Nils; Roes, Kit; de Vries, Sieta T; Wettermark, Björn
发表日期：2026
文献求助 收藏

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real-World Data Sources for Fit-for-Purpose Studies

驾驭现实世界：有效识别、评估和选择适用于特定用途研究的现实世界数据源的结构化框架的范围界定综述

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3746
Zebachi, Sonia; Tanniou, Julien; Bakker, Elisabeth; de Vries, Sieta T; Di Bidino, Rossella; Xoxi, Entela; Glaser, Anna; Savarese, Gianluigi; Hillert, Jan; Mol, Peter G M; Plueschke, Kelly; Amzal, Billy; Hayek, Ghinwa Y; Moreira, Jeverson
发表日期：2025
文献求助 收藏

Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study

关于澳大利亚新型数字药物不良事件报告平台开发和使用的观点：一项定性研究

期刊:Drug Safety
影响因子:3.8
doi:10.1007/s40264-024-01489-3
Gebreyohannes, Eyob Alemayehu; Thornton, Christopher; Thiessen, Myra; de Vries, Sieta T; Coombs, Gretchen; Hwang, Indae; Lim, Renly
发表日期：2025
文献求助 收藏

Stakeholders' Perspectives Toward the Use of Patient Registry Data for Decision-Making on Medicines: A Cross-Sectional Survey

利益相关者对利用患者登记数据进行药物决策的看法：一项横断面调查

期刊:Drug Safety
影响因子:3.8
doi:10.1007/s40264-025-01528-7
Windfuhr, Fabian; de Vries, Sieta T; Melinder, Maria; Dahlqvist, Tanja; Almeida, Diogo; Sepodes, Bruno; Torre, Carla; Wettermark, Björn; Mol, Peter G M
发表日期：2025
文献求助 收藏

Views of European Union medicine regulators and healthcare professionals on the approved versus prescribed dose of protein kinase inhibitors: an interview study

欧盟药品监管机构和医疗保健专业人员对蛋白激酶抑制剂的批准剂量与处方剂量的看法：一项访谈研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-101053
Brinkhof, Margot; de Vries, Sieta T; Mol, Peter G M; Trapani, Dario; Marije de Jong, Irja; Broekman, K Esther
信号转导
发表日期：2025
文献求助 收藏

Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing

2型糖尿病患者对评估降血糖药物偏好的决策辅助工具的看法：选择的困境

期刊:Patient Preference and Adherence
影响因子:2
doi:10.2147/PPA.S486553
Roldan Munoz, Sonia; Mol, Peter G M; de Vries, Femke; van Dijk, Peter R; Hillege, Hans; Postmus, Douwe; de Vries, Sieta T
糖尿病
代谢
发表日期：2025
文献求助 收藏

Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project)

共同设计以消费者为中心的数字健康报告平台，以改进不良药物事件报告：多方法研究项目方案（ReMedi 项目）

期刊:JMIR Research Protocols
影响因子:1.5
doi:10.2196/60084
Gebreyohannes, Eyob Alemayehu; Thornton, Christopher; Thiessen, Myra; de Vries, Sieta T; Q Andrade, Andre; Kalisch Ellett, Lisa; Frank, Oliver; Cheah, Phaik Yeong; Choo, Kim-Kwang Raymond; Laba, Tracey Lea; Roughead, Elizabeth E; Hwang, Indae; Moses, Geraldine; Lim, Renly
发表日期：2025
文献求助 收藏

Use cases of registry-based randomized controlled trials-A review of the registries' contributions and constraints

基于注册登记的随机对照试验的应用案例——注册登记的贡献和局限性综述

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70072
Kubesch, Nadine; Gaitonde, Sneha; Petriti, Uarda; Bakker, Elisabeth; Basu, Swati; Birks, Laura Ellen; Aubrun, Elodie; de Vries, Sieta T; Schneider, Rahel
发表日期：2024
文献求助 收藏

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial

高剂量烷化剂化疗治疗 BRCA 基因突变的三阴性乳腺癌：随机 III 期 NeoTN 试验

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-023-00580-9
Vliek, Sonja; Hilbers, Florentine S; van Werkhoven, Erik; Mandjes, Ingrid; Kessels, Rob; Kleiterp, Sieta; Lips, Esther H; Mulder, Lennart; Kayembe, Mutamba T; Loo, Claudette E; Russell, Nicola S; Vrancken Peeters, Marie-Jeanne T F D; Holtkamp, Marjo J; Schot, Margaret; Baars, Joke W; Honkoop, Aafke H; Vulink, Annelie J E; Imholz, Alex L T; Vrijaldenhoven, Suzan; van den Berkmortel, Franchette W P J; Meerum Terwogt, Jetske M; Schrama, Jolanda G; Kuijer, Philomeen; Kroep, Judith R; van der Padt-Pruijsten, Annemieke; Wesseling, Jelle; Sonke, Gabe S; Gilhuijs, Kenneth G A; Jager, Agnes; Nederlof, Petra; Linn, Sabine C
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study

哪些因素促使欧盟监管机构希望就SGLT2抑制剂相关的药物安全问题进行沟通？一项在线调查研究

期刊:Drug Safety
影响因子:3.8
doi:10.1007/s40264-022-01270-4
Roldan Munoz, Sonia; Postmus, Douwe; de Vries, Sieta T; Gross-Martirosyan, Liana; Bahri, Priya; Hillege, Hans; Mol, Peter G M
SGLT2
发表日期：2023
文献求助 收藏